We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$11.4B
AUM Growth
+$466M
Cap. Flow
-$346M
Cap. Flow %
-3.04%
Top 10 Hldgs %
11.96%
Holding
2,051
New
157
Increased
773
Reduced
962
Closed
143

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Healthcare 11.82%
3 Financials 9.9%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIF
1401
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
$598K 0.01%
41,504
+10,624
+34% +$153K
RXDX
1402
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$598K 0.01%
+5,439
New +$353K
FLG
1403
Flagstar Bank National Association
FLG
$5.82B
$597K 0.01%
23,153
+3,192
+16% +$85.5K
NVAX icon
1404
Novavax
NVAX
$1.31B
$594K 0.01%
57,827
+17,645
+44% +$311K
BPOP icon
1405
Popular Inc
BPOP
$11.1B
$592K 0.01%
+8,932
New +$621K
VCSH icon
1406
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$590K 0.01%
7,849
-334
-4% -$25K
GHC icon
1407
Graham Holdings Company
GHC
$5.02B
$590K 0.01%
976
+379
+63% +$231K
AMRC icon
1408
Ameresco
AMRC
$1.36B
$588K 0.01%
10,292
-441
-4% -$26.9K
BNS icon
1409
Scotiabank
BNS
$108B
$586K 0.01%
11,969
-2,248
-16% -$111K
COWN
1410
DELISTED
Cowen Inc. Class A Common Stock
COWN
$584K 0.01%
15,109
+9,145
+153% +$353K
SIGI icon
1411
Selective Insurance
SIGI
$5.73B
$583K 0.01%
6,578
+3,999
+155% +$364K
AROC icon
1412
Archrock
AROC
$5.8B
$581K 0.01%
64,668
-53,681
-45% -$430K
EFX icon
1413
Equifax
EFX
$21.4B
$579K 0.01%
2,980
-4,485
-60% -$820K
EDIT icon
1414
Editas Medicine
EDIT
$442M
$578K 0.01%
65,112
+15,113
+30% +$166K
LYV icon
1415
Live Nation Entertainment
LYV
$42.1B
$576K 0.01%
8,261
+1,585
+24% +$117K
PNR icon
1416
Pentair
PNR
$11B
$576K 0.01%
12,801
-7,116
-36% -$309K
IT icon
1417
Gartner
IT
$11.7B
$574K 0.01%
1,707
-3,786
-69% -$1.22M
GNL icon
1418
Global Net Lease
GNL
$1.95B
$571K 0.01%
45,433
-57,337
-56% -$711K
BIO icon
1419
Bio-Rad Laboratories Class A
BIO
$9.42B
$569K 0.01%
1,354
-238
-15% -$96.1K
OPI
1420
DELISTED
Office Properties Income Trust
OPI
$569K 0.01%
42,634
-5,538
-11% -$79.8K
HST icon
1421
Host Hotels & Resorts
HST
$16B
$569K 0.01%
35,442
-248
-0.7% -$4.34K
MKTX icon
1422
MarketAxess Holdings
MKTX
$5.72B
$568K 0.01%
2,038
-1,136
-36% -$292K
DEA
1423
Easterly Government Properties
DEA
$1.18B
$568K 0.01%
15,928
+1,066
+7% +$41.5K
CPE
1424
DELISTED
Callon Petroleum Company
CPE
$568K 0.01%
15,305
-2,478
-14% -$102K
GRMN
1425
Garmin
GRMN
$60B
$567K 0.01%
6,146
-1,384
-18% -$122K

Similar funds

Guggenheim Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Guggenheim Capital held 2,051 positions worth $11.4B, up 4.3% from $10.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Guggenheim Capital withdrew a net $346M in Q4 2022, closing 143 positions and reducing 962 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Guggenheim Capital opened a new position in Guggenheim Active Allocation Fund worth $4.25M.

  • Guggenheim Capital's largest Q4 2022 buy was Guggenheim Active Allocation Fund: 315,680 shares worth $4.25M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $43.4M increase.
  • Guggenheim Capital's biggest Q4 2022 reduction was Apple, cutting an estimated $22.7M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $109M.
  • Guggenheim Capital's ten largest holdings make up 12% of its $11.4B portfolio in Q4 2022.
  • Guggenheim Capital opened 157 new positions and closed 143 in Q4 2022.
  • Guggenheim Capital's portfolio value rose 4.3% quarter-over-quarter to $11.4B.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.